Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy
Metadata only
Date
2019-02-15Type
- Review Article
Publication status
publishedExternal links
Journal / series
Advanced Drug Delivery ReviewsVolume
Pages / Article No.
Publisher
ElsevierSubject
Immunocytokine; Immunotherapy; Biopharmaceutical; Armed antibody; Antibody engineering; Targeted therapy; Combination therapy; Check-point inhibitor; Cytokine; CancerFunding
163479 - Understanding and Exploiting the Molecular Targeting of Tumor Neo-vasculature (SNF)
670603 - Fulfilling Paul Ehrlich’s Dream: therapeutics with activation on demand (EC)
More
Show all metadata